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INTRODUCTION 
The purpose of this investigation was to make a quantitative study 
of the alterations in the fecal flora of normal healthy subjects follow-
ing oral administration of aureomycin. Fecal specimens from these subjects 
were studied daily before medication, during medication and following the 
medication for a varying number of days until the fecal flora had returned 
to pre-drug levels. The data are herewith presented• analyzed and 
evaluated. 
IV 
REVIEW OF THE LITERATURE 
Since the discoveries of various antimicrobial agents (chemothera-
peutic agents) their effects on the intestinal flora of man and lovrer 
ani~Bls have become increasingly interesting to microbiologists, gastro-
enterologists, abdominal surgeons, agriculture.! researchers, and nutri-
tionists. This review of the literature is intended to cover briefly 
all the important work thus far done on the alteration in normal 
intestinal flora of man and animals treated with the commonly used anti-
microbial agents. Emphasis will be given with reference to aureomycin 
and terramycin. The problem of developing bacterial resistance toward 
these agents will be mentioned wherever indicated. 
Tyrothricin 
As early as 1941, Weinstein and Rammelkamp (132) reported that tyro-
thricin had no effect on Lactobacillus acidophilus ~~even when 160 
times the in vitro killing dose was given to mice. 1~o possibilities were 
formulated to explain this discrepancy. One is that tyrothricin may be 
destroyed by the pancreatic or intestinal juices of the animal. Another 
possible expla.nation for the failure of tyrothricin to kill L. acidophilus 
in the living animals may be that the bactericidal agent is inhibited by 
the fecal wBterial. Tyrothricin was not found to produce any local lesions 
in the gastrointestinal tract of the animal in this study. No similar 
study with tyrothricin has appeared in the literature since. 
Sulfonamides 
The effect of sulfonamides on normal intestinal flora did not become 
a subject of extensive study until the poorly absorbed sulfonamides were 
discovered. Moae of the studies done in this regard are either as a part 
1 
of nutrition experiments on animals or in an attempt to find a suitable 
antimicrobial agent for the intestinal antisepsis in man. The latter 
has been of particular interest to surgeons looking for possible measures 
to cut down the incidence of septic complications following operations on 
the gastrointestinal tract. MUch effort has been expended in the hope of 
finding a poorly absorbed sulfonamide ~ich would alter significantly the 
bacterial flora of the gastrointestinal tract without adversely affecting 
the ho nt.. Marshall and his associates (74) were probably the first group 
o£ investigators to report, in 1940, that marked reduction of coliforms 
' (in man and mice) followed oral administration of sulfanilylguanidine. 
Firor and Poth (41) later indicated that this compound did not decrease 
the number of bacteria other than coliforms in the colon of man and the 
dog and there was no reduction even in coliforms in presence of ulcerative 
lesions of the bowel. The ineffectiveness of sulfaguanidine in presence 
of ulcerative colitis was later confirmed by Vieta and Stevenson (128). 
In 1941 Path end his associates (92, 93, 94) found that succinylsulfa-
thiazole (sulfasuxidine) markedly diminished the coliforms in the bowel 
of man and the dog in 1 to 7 days in 95 per cent of cases. This marked 
reduction in the number of coliforms was supported by Welch and his 
associe.tes (135), Gant and his associates (43), Lockwood (70) and others -
(31, 6}. Lockwood (70) ~ound that in addition to the marked reduction 
~rom loll to 105) of the gram-positive bacteria in certain clinical cases 
as previously described by Path and his co-workers (94) the drop in number 
of clostridia (welchi) paralleled rather closely the drop of coliforms and 
that there was an increase in the total number of streptococci during the 
supoinylsulfathiazole treatment. Firor (39), Kirby and ~antz (65), and 
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Gant and his associates {43) reported a similar increase of enterococci 
during medication. Gant and his associates (43) also found that in rats 
given sulfaguanidine or sulfasuxidine the coliform counts remained low 
for 10 days and then began to increase and at the end of the five weeks 
of medication almost approached tbe normal pre-drug level. This increase 
of coliforms or Escherichia ~ during the later period of medication 
was later confirmed by Evenson and his co-workers (31) who also reported 
increase of yeast-like organisms during medication. Archer and Lehman 
(6) showed that the presence of ulcerative lesions did not interfere with 
the effect of sulfasuxidine and that the patients receiving a considerable 
amount of protein in their diet presented a course of more rapid decline 
of coliforms than .' those without. 
Firor and Jones (40) first used sulfanilylguanidine in the pre-
operative preparation of 12 patients subjected to surgical procedures on 
the colon and reported gratifying results. Allan (1) remarked upon the 
unusually smooth convalescence follmving combined abdominoperineal resec-
tion after the use of sulfasuxidine. Poth (86) in a review of thera-
peutic agents for intestinal antisepsis re-emphasized the value of sulfa-
suxidine as a useful adjuvant in surgery of the colon and formulated an 
outline for the proper use of this drug. A few more poorly absorbed 
sulfonamides were then di scovered from time to time. Callomon and 
Raiziss (16) reported in 1943 that the bactericidal effect of succinyl 
sulfaPXt"azine is much greater than that; of sulfasuxidine and is at l east 
equal to or greater than that of sulfaguanidine. Poth and Ross (97, 98 
85) found that phthalylsulfathiazole (sulfathalidine) had 2 to 4 times 
the bacteriostatic activity of sulfasuxidine in the bowel of man or dog. 
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Microorganisms were usually greatly decreased in 24 hours and coliforms 
were ordinarily reduced to less than 11 000 per gram of wet feces within 
3 days. Further studies of Poth and Ross {99 1 87) showed that sulfa-
thalidine caused more rapid . reduction of coliforms and clostridia, less 
tendency to form semi-liquid stools and were better suited to patients 
with ulcerative colitis and watery diarrhea than sulfasuxidine. The 
enterococci were however not affected. .Among- a fmv reports of recent 
years, Dearing and Heilman (20) claimed that sulfasuxidine and sulfa-
thalidine are far from being efficient as antibacterial agents against E. 
coli. Furthermore, Streptococcus fecalis always tended to increase in 
number as the medication was continued and clostridia were present in the 
culture eventually in 21 of 35 patients during adequate medication. 
Ganey and his associates (42) in 1950 presented evidence that during sulfa-
suxidine therapy (0.25 gram per kilo per day far 7 days) the reduced coli-
forms started to increase in number on the 4th day of the treatment and 
reached a level much higher than the initial pre-drug level on 5th day 
after discontinuance of the drug. There was considerable increase of 
Proteus and clostridia in addition to the increase of streptococci 
previously reported by many other investigators. The same group of workers 
also found formosulfathiazole to be a much better bacteriostatic agent on 
intestinal flora. Formosulfathiazole is a condensation product of sulfa-
thiazole and formaldehyde. It is poorly absorbed from the intestinal 
tract. Seven out of 10 patients given 2 grams' of this drug orally every 
8 hours for 7 days showed a marked reduction in coliforms and total 
organisms at the end of 72 hours of medication. This drug also reduced 
the number of Proteus and streptococci in addition to the clostridia. 
. This inhibitory action lasted over a period longer than 5 da~~ after dis-
continuance of the drug. The total bacterial counts, however. started to 
go up slowly after the 4th day of medication. Zenker and Groll (140) 
advised the use of the combination of formosulfa.thiazole and streptomycin 
to give a better bacteriostatic effect. 'l'he suppre-ssive effect of forma-
sulfathiazole upon Proteus was recently confirmed by the work of Marmell 
and his co-workers (73) who also found a decrease in aerobic and anaerobic 
spore-forming bacteria and no increase in yeast-like organisms. Follwing 
a. temporary decrease in number. the enterococci, however increased 
tremendously during medication with formothiazole and might replace all 
the other flora. 
The development of resistance to sulfonamides by the intestinal 
flora has not been as serious a problem as the development of resistance 
to streptomycin. Kirby and Rantz (64) showed by 2:!!, vitro studies that 
the resistance of E. coli to sulfonamides developed gradually and could 
be d·emonstrated for all 4 drugs tested: sulfanilamide, sulfapyridine. 
sulfathiazole and sulfadiazine. A common structural unit possessed by 
these drugs and an interaction involving the same enzyme system were 
suggested to explain the development of cross resistance. Harris and 
Kohn (50) pointed out that the resistance of the bacterium not only de-
pends upon the medium in which ntraining11 occurred, but also upon the 
medium in which the measure of resistance is made. 
Penicillin 
Few studies concerning the effect of penicillin on the intestinal 
flora he.ve been made, probably because of the insusceptibility of the 
predominating gram-negative bacteria of bowel to this antibiotic. 
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Thomas and Levine (125) in 1945 1 found that in vitro the gr~negative 
bacilli of the intestinal tract seemed to fall into the following order 
of descending susceptibility to penicillin: Salmonella1 Proteus, Shigella, 
EscheriQbia, and Aerobacter. These organisms were affecte~ only when the 
concentration of penicillin was extraordinarily high. They also reported 
changes in cultural characters and the development of bizarre involution 
forma. These varied from large, long, twisting filaments to calls re-
sembling deformed integral signs, Pasteur flasks, swelled fusiform bacilli, 
large globular calls and irregular masses. Weinstein (131) in 1946 
succeeded in producing complete suppression of the growth of cultures con-
taining standardized inocula of both E. coli and Staphylococcus aureus 
. --
with 3 per cent ure't;hane or 6 per cent urea combined with 0.1 unH; of 
penicillin. Lipman and his associates (67) reported in 1948 that penicillin 
given to arthritic patients caused a lower incidence of enterococci but 
showed no noticeable effect on the enteric bacilli and the anaerobes. 
Anderson and his co-workers (3) reported in 1952 that in a study of 
chicks fed a diet containing 10 p.p.m. of penicillin and 23 per cent of 
protein, the antibiotic caused a reduction in pH of the cecal contents, 
increase of lactobacilli, aciduric organisms and coliforms, especially 
atypical E. ~~ e:nd some reduction of enterococci. The drug also 
markedly increased the size of ceca and enhanced the oxygen intake of 
lactobacillus and aciduric type~ of organisms. Recently Guzman-Garcia 
and his associates (47) found that in rats fed penicillin (25 mg per kilo-
gram) there was a marked increase in the number of coliforms (about 100 
times) in the cecum and small intestine from the 7th day of the treatment 
through the 28th day. The numbers of anaerobes declined during the first 
6 
week but the effect disappeared after 2 weeks. There appeared to be 
slight reduction of lactobacilli. Enterococci were not altered. In the 
presence of a diet deficient in thiamine 11 the drug caused a marked 
increase in the growth of the rats. 
Streptomyoin 11 Neomycin 1 Polymyxin and Bacitracin 
Before the rapid development of bacterial resistance against strep-
tomycin became a serious problem, streptomycin appeared very promising 
for suppressing the predominately gram-negative intestinal flora. Smith 
and Robinson ~18) reported in 1945 that streptomycin was much more 
effective than streptothricin, sulfaguanidine 11 and sulfasuxidine in both 
the rate and the exten·t of reduction of the number of intestinal organisms 
in mice. Within 24 hours after the beginning of treatment with 30,000 
units of oral streptomycin per kg per day the coliform count decreased 
1 11 000-fold and the numbers of non-lactose fermenting organisms decreased 
200-fold. When the streptomycin dosage was raised to 300 1 000 units per kg 
per day, it eliminated not only all coliforms, but all gram-negative 
organisms, leaving only a small number of gram-positive spore -formers such 
as Bacillus subtilis. This decrease or elimination of organisms persisted 
throughout the 3-week period of treatment. Emergence of Pseudomonas 
aeruginosa and staphylococci was not encountered. Kane and Foley (62) in 
1947 found that oral administration of as little as 1.0 g of streptomycin 
daily eliminated E. coli from the stools of 5 patients within 2 days. The 
fecal streptococci, clostridia, Bacteroides, and Candida were unaffected. 
They concluded that streptomycin is much more effective than sulfonamides 
in ridding the colon of~· coli for preoperative preparation of patients 
who are to undergo surgery of the colon. This view was supported by Zintel 
7 
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and others (142) who in addition claimed that this antibiotic ~lso de-
creased the number of Str. faecalis and clostridia. Rowe, Spaulding and their 
co-workers (108, 120) reported that the combination of sulfathalidine and 
streptomycin caused more rapid reduction of the coliform count than either 
drug used alone. This was, however, not confirmed by Poth and his 
associates (96) and Lockwood and his colleagues (71). Furthermore, 
Locla~ood and his colleagues advised against the use of streptomycin for 
preoperative use because of the risk of the development of resistance 
and the establishment of a highly resistant flora at the time of operation. 
Spaulding and his associates (120) pointed out that the combination of 
streptomycin and sulfathalidine did not prevent the development of strep-
tomycin resistance and in 2 cases treated with this mixture there vms a 
definite reversion of the lmv coliform count due to rapid proliferation 
of resistant Aerobacter aerogenes while the treatment was still continued. 
The increase of coliforms began on 5th day of the treatment in one 
instance and on the 9th day in the other. De Van (19) in a study of 40 
patients treated preoperatively with 1 gram of streptomycin by mouth 
every 6 hours for 5 days found that the stool became sterile for aerobic 
and anaerobic organisms in 37.5 per cent of cases at the end of 48 hours 
and in 47.5 per cent after 72 hours. The earliest time for the resistant 
organisms to appear was 4 to 5 days after the beginning of the treatment. 
This time limit agrees fairly well with the findings of Spaulding and his 
associates (120) and Pulaski and his associates (104) • . The preoperative 
use of streptomycin was therefore advised to last not longer than 2 or 3 
days and moderates doses of Vitamin K should be given to counteract any 
tendency to develop hypoprothrombinemia. 
Pulaski and his associates (104) reported in 1950 that when 8 
normal subjects and 6 patients were given 0.5 g streptomycin, combined 
with 2 g o£ glucuronolactone, by mouth 4 tL~es daily, !• coli was 
completely suppressed within 24 to 48 hours and the period o£ suppression 
could be lengthened to 14 days or more. Micrococci were reduced in 
number inconstantly but signi£icantly. Clostridia, Bacteroides and 
Candida were una£fected. !• coli reappeared within 48 hours a£ter the 
treatment had been discontinued in a case treated £or 33 days but was 
again suppressed £or another 7 days when the therapy was reinstituted. 
The advantage of combining streptomycin with glucuronolactone was con-
firmed by Welch and his co-workers (136). On the other hand, Donaldson 
and Bricker (28) reported that only 40 per cent o£ patients showed 
reduced numbers of coliforms and 65 per cent showed reduced numbers of 
streptococci and that in 7q per cent of patients either the coliform or 
the enteric streptococcic bacteria developed streptomycin-resistant 
strains within the first 48 to 96 hours after the start of this combined 
therapy, as evidenced by the return of their number to normal or higher 
than normal. 
Neomycin isolated from Streptomyces fradiae was first described 
by Waksman and Lechevalier (130) in 1949 and soon proved to be much more 
promising than streptomycin for alteration of intestinal flora. Poth and 
his associates (88, 90, 91, 95) found that in man and dog treated vnth 0.1 
gram per kilo of body weight per day all the culturab~e bacteria could be 
eliminated from the gastro-intestinal tract within 24 hours. This new 
~~tibiotic did not favor the development o£ resistant strains but in 
approximately 10 per cent of patients it failed to inhibit the growth o£ 
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A. aerogenes. Therefore, combined therapy with sulfathalidine was 
suggested for preoperative use to inhibit~. aerogenes. Either this 
combined therapy or neomycin alone still failed to inhibit the growth 
of the yeasts. 
Finegold (32) claimed that oral administration of bacitracin could 
profoundly affect Str. faecalis and clostridia and that apparently low 
counts could be maintained for at least 2 or 3 weeks on continued treat-
ment. He also found that the combinat ion of streptomycin and bacitracin 
offered the better results than those obtained with either antibiotic 
alone. Welch and his co-workers (136) reported promising results with 
a combination of bacitracin and streptomycin in obtaining a. greater 
reduction of coliforms and with Polymyxin B to counteract the strepto-
mycin-resist~~t organisms. This streptomycin-bacitracin-polymyxin mix-
ture could completely eliminate the coliforms by the 4th day of the medi-
cation and the coliforms remained absent until 3 days after discontinuance 
of the medication. Poth (88) recently concluded that bacitracin is of 
little value, when used alone. It is mainly effective against gram-
positive bacteria including penicillin-resistant varieties (10, 104). 
The poorly absorbed Polymyxin B is extremely active against many 
gram-negative bacilli especially Pseudomonas aeruginosa. and streptomycin-
resistant coliforms. Pulaski and his associates (103, 104) reported that 
Polymyxin B, in a. total daily oral dosage of only 200 to 400 mg, could 
eliminate all the coliforms as rapidly as streptomycin but the cocci, 
Proteus and clostridia. e.ppeared to be unaffected. Drug-fastness did 
not occur readily. Recently Jawetz and Bierman (58) found that in patients 
treated with a daily ore.l dosage of 400 mg of .Polymyxin B, within 24 to 72 
10 
hours there was a reduction of the coliform com1t to 1,000 or less per 
grrum of wet feces, together vdth some reduction of total anaerobes and 
an inconsistent suppression of the spore-forming anaerobic bacilli. 
This suppression lasted for 2 to 5 days after the oral medication had 
been discontinued. Enterococci were not significe.ntly affected. A 
mixture of pol~~yxin ~~th either neomycin or bacitracin appeared to be 
much more active than the single components. They markedly suppressed 
the en·terococci, Proteus and Pseudomonas in addition to complete 
suppression of the coliforms. Polymyxin-resistant coliform was encountered 
during medication in one instance in their series of 14 patients. 
Since the development of drug-resistant organisms has become a 
serious problem, especially in the case of streptomycin, a tremendous 
e~ount of research has been done in an endeavor to learn the nature of 
the development of resistance. Since this investigation is not concerned 
with this problem, it ~~11 not be discussed here. For information concern-
ing antibiotic resistance see the papers published by Braun(ll), Demaree 
(25, 26), Sevag and Rosanoff (116), Gibson and Gibson (46). 
In addition to the development of drug resistance, the spontaneous 
occurrence of new infections due to insusceptible organisms originally 
present in the patient's body is by no means rare. Weinstein (133) in 
1947 described 5 such cases. In one patient who probably had atypical 
virus pneumonia, the administration of penicillin resulted in an over-
grov~h of Hemophilus influenzas in the pharynx, followed by an invasion 
of the blood and respirat ory tract. In another penicillin-treated patient 
there was spontaneous occurrence of pnemnonia due to FriedlRnder' s 
bacillus. The remaining 3 cases were treated with streptomycin for H. 
11 
influenzas infections, e~d one developed bronchopneumonia with bacteremia, 
another meningitis with bacteremia, and a third recurrent pyelonephritis, 
e.ll due to hemolytic Staph. aureus. These superinfections are merely a 
re sult of rapid proliferation and invasion of the normal inhabit~ts 
following reduction or elimlnation of the real infectious agents. More 
illustrations will be given vmen the other antibiotics are reviewed. 
Chloromycetin, Aureomycin and Terramycin 
12 
The advent of 'these broad-spectrum e.ntibiotics has made the hope 
greater than ever before that the administration of a single antimicrobial 
agent could eliminate from the inte stinal flora as many species as possible. 
Chloromycetin (Chloramphenicol) is not generally considered to be a 
good preoperative intestinal antiseptic (88, 106). Ganey and his associates 
(42) noted an increase in Proteus and clostridia during ohloromycetin 
treatment. Bierma.n and Jawetz (9) found an increase of staphylococci• 
Pseudomonas, and yeasts during the therapy. Pulaski and his as socie.tes 
(101, 102, 103) did not consider chloromycetin promising, as it suppressed 
only E. ~ among the normal intestinal flora. They also noted the return 
of the E. coli and eventual increase of the total bacterial count to above 
pre-drug levels. Dearing and Heilme.n (20) gave chloromycetin in doses of 
750 mg 4 tlines daily for from 2~ to 12 days, but did not find it reliable 
or effective. 
Aureonzycin (chlortetracycline) and terramycin (oxytetracycline) are 
very similar in structure as well as in their spectra of antibiotic 
activity. Conflicting reports have appeared concerning the ability of 
these antibiotics to reduce the bacterial population of the intestine. 
!~y investigators have published favorable findings. Early reports by 
Finland and his associates (36, 37) indicated. that as a prophylactic 
agent aureomycin had proved superior to the combination of streptomycin 
and the poorly absorbed sulfonamides. · The total bacterial counts of 
both Gram-positive and Gram-negative organisms in the lower bowel contents 
dropped rapidly and remained persistently low for long periods during oral 
administration of aureomycin. Neter (82), in a few cases ·treated with 
aureomycin, was able to sterilize the bowel contents. Dearing and Hail-
man (20, 21) reported in 1950 that all the culturable bacteria except 
Pseudomonas and Proteus were removed within a period of from 1~ to ~ 
days fromthe start of oral aureomycin therapy in 75 out of 91 patients. 
They concluded that aureomycin showed great promise and superiority over 
many other antimicrobial agents including ohloromycetin, dihydrostrepto-
mycin, sulfasuxidin~, and sulfathalidine studied at the same time. During 
the same period Baker and Pulaski (7) and DiCaprio ar.d Rantz (27) 
published favorable reports on the preoperative use of terramycin. Baker 
I 
and Pulaski found that the coliform bacteria were rapidly elimina.ted in 
10 of 11 patients and streptococci were eliminated in 6 of the 11 patients, 
and suppressed in 2 others. McVay (78) reported in 1952 that in 9 
patients treated with one gram of aureomycin daily for 2 days, marked or 
complete inhibition of 7 out of the 8 kinds of bacteria studied occurred 
within 24 to 48 hours and the definite reduction of these orge.nisms per-
sisted for 2 days after medication had been discontinued. Using 3 g of 
the drug daily for 2 days, he was able to demonstrate complete inhibition 
of 6, including E. ~~ anaerobic streptococci, Bacteroides, ~· 
viridans, Str. pyogenes, and Clostridium perfringens. Str. faecalis and 
A. aerogenes were not uniformly inhibited. Dearing, Mann and Needham 
13 
(23) found that in 14 patients treated with 3 g of terramycin daily for 
I 
from 3 to 5 days there were similar changes and in addition there was 
disappearance of yeasts and Proteus in a majority of the cases. An dina 
and Allemann (5) and Breitman and his associates (13) advocated the use 
of the less soluble amphoteric terramycin in smaller doses to get a 
greater antibiotic activity in bowel. Other favorable reports concerning 
studies upon man with these antibiotics were given by Sborov and his 
associates (111), River~and Sborov (107) and Riddell (106). Studies of 
poults, chicks and rats (4, 30, 112, 113, 117, 119) have shown marked 
alterations in fecal flora similar to those in man. These antibiotics 
in proper dosage (s~ll) could also lead to rapid and extra growth of 
pigs, calves, rats, chicks, turkey poults, etc. (4, 30, 59, 61, 109). 
It has been postulated that these antibiotics may promote growth in that 
they conserve a given vitamin for the host by inhibiting or reducing the 
intestinal flora which would compete with the host for that vitamin. 
In contrast to all the favorable reports mentioned above, many 
other investigators have found less satisfactory or unsatisfactory re-
sults with these two' broad-spectrum antibiotics. Metzger and Shapse 
(76) reported in 1950 that, in their experience, administration of aureo-
mycin did not cause a significant diminution of any prominent member of 
the intestinal flora '. They concluded that administra tion of aureomycin 
alone does not appear to be effective in reducing the colonic flora 
prior to surgery, and furthermore that the suppression of coliform flora 
may be detrimental by allowing the development of a highly resistant 
flora. Ganey and his associates (42) found that only one out of ten 
2atients treated with aureomycin, 3 g per day, and 5 out of 10 patients 
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· tree.ted V'.ri th the same dosage of terramycin showed a. reduction in coli-
forms. These patients at the same time showed an i ncrease in the total 
colony count s. Less : satisfactory results with terrrunycin and aureomycin 
were also reported by Wright and Prigot (138) and Dearing and Needham 
(24) during 1951. Poth f88, 89) in 1952 pointed out that these anti-
biotics are inferior . to neomycin for intestinal antisepsi s. Further-
! 
more they cause untoward gastrointest inal reactions and rapid growth of 
insusceptible yeasts and Staph. aureus. Among a few recent reports 
Morton, Riddell e.nd Murray{81 ) commented that the e.ctual effect of terra-
mycin alone on the r~duction of the fecal flora is of no value. Although 
there was a reduction in the number and species of coliforms in the 10 
I 
patients they studied , the total bacterial counts remained at high 
I 
levels, even with doses as large as 2 or 3 g a day. In addition, the 
antibiotic-resistant Proteus and Pseudomonas appeared in a great many of 
the ca ses an d completely dominated the subsequent feoa.l flora. Tyson 
and his co-workers (127) in studying 19 patients treated with 1.5 or 3 g 
I 
of terramycin per day pre sented a similar picture. The essential change 
was a replacement of~ coli by enterococci, Proteus, and yeasts. There 
was a.n initial small idrop in total count followed by an elevation of 
total count to above ' the pre-drug level. Lactobacillus and Aerobacter 
I 
were eliminated or r~duced. The predominating enterococci showed a 
rapid increase in resistance. They re~~rked that t his alteration of 
the fecal flora, with an increase in numbers, and consisting of organisms 
resistant not only to the drug used but to 2 similar broad-spectrum anti-
bi otics is certainly undesirable. Nfu re recently Allen's (2) study of 48 
patients treated v.rith 1 to 4 g of terramycin daily has further substan-
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tiated the findings of .the previous investigators. ·He found that oral 
administration of terramycin did not sterilize the colon. 'I'he 11total 11 
number of bacteria in the intestinal contents was actually increased due 
to greater numbers of streptococci1 yeasts and Proteus during the treat-
ment. Resistant strains of coliforms and lactobacilli appeared during 
the second week of the therapy. 
Among the disadvantages of the use of these broad-spectrum anti-
biotics as intestinal antiseptics, the rapid proliferation of resistant 
organisms to cause severe superinfections is far more important than the 
toxicity and ineffectiveness of the drugs and has become a great concern 
· to us. The rapid proliferation of the foll~ting drug-resistant organisms 
has been c:onnnonly encountered as serious complications of the antibiotic 
therapy:-
Pathogenic staphylococci 
Finland and his colleagues (35) reported in 1951 that diarrhea 
associated vdth recovery of pathogenic staphylococci in large numbers 
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and sometimes in ~ure culture had been noted in some patients during anti-
biotic therapy. The sa.me group of investigators (55) again reported that 
37 of 91 patients treated with terramycin for pneumonia developed diarrhea; 
cultures of the stools were made. in 18 of these patients and in 12. Staph. 
aureus resistant to penicillin, terramycin, and aureomycin was found as the 
only or the predominant organism in the watery feces. The staphylococcal 
diarrhea may have been an important contributing factor in the fatal out-
come of at least 3 of these patients. During the next year Janbon and 
his associates (56 1 57) in France observed 3 deaths out of 9 patients who 
manifested a choleriform diarrhea associated with staphylococci during 
terramycin treatment for various infections. M:ore reports concerning 
staphylococcal diar~hea have appeared since 1953. Dearing and Heilman 
(22) presented 44 patients, in 43 of whom staphylococci were found in 
stool cultures; 39 of these had received terramycin; suooinylsulfathia~ 
zole, penicillin in addition to dihydrostreptomycin, and aureomycin had 
each been used in 1 patient, and 2 had no antimicrobial therapy. A 
majority of the patient having staphylococci developed diarrhea. Death 
following the staphylococcal diarrhea occurred in 6 cases, 5 of these 
having received terramycin e~d 1, aureomycin. A 7th ter~amyc~n patient 
diad of severe diarr~ea and shock due to pseudomembranous ileocolitis, 
but no staphylococci were found on cultures. Other cases of severe 
diarrhea due to drug-resistand staphylococci or suspected to be so 
following the use of broad-spectrum antibiotics includeS casas from 
Terplan and his associats 024), 2 cases from Gardner (44), 7 cases from 
Reiner and others (105), 2 cases from Bernhart (8), 3 cases from Maier 
(80) etc. Very recently Finland and his associates (34) reported that 
among 520 patiepts treated with terramycin or aureomycin hemolytic Staph. 
aureus was found as the only or predominant organism in one or more 
cultures from 27 of the 38 terramycin-treated patients and from 4 of 
the 22 aureomycin-treated patients; all of them had diarrhea during 
medic.ation. There were 2 and probably 6 additional terramycin-treated 
patients in whom staphylococcic diarrhea may have contributed to their 
fatal outcome. Only one aureomycin-treated patient could fall into this 
category. The incidence of strains of staphylococci resistant to peni-
cillin and· to these broad spectrum antibiotics has been rapidly increas-
ing almost everywhere with the extensive use of these antimicrobial 
17 
agents (33, 66, 134). They could be widely spreading as evidenced by 
the findings of Dowling and others (29). To suppress these drug-
resistant strains, Dearing and Heilman (22) and Haight and Finland 
(48) found erythromycin promising. Recently, Spink (121) advocated 
combining erythromycin with bacitracin. Howe (53) has noted favorable 
results with carbomycin in a few clinical trials. 
Yeasts 
Infl~tory lesions of mucous membranes following prolonged use 
of these antibiotics were at first considered to be avitaminosis caused 
by suppre ssion of the intestinal f lora (83). ~robably the yeasts were 
not incriminated until the time when Farber (1 41) reported a case of 
dissemine.ted moniliasis following antibiotic therapy a:qd Harris ( 49) 
I 
isolated Candida albicans f'rom 5 of' 25 patients who had had acute 
i nfl armnatory disease of' mucous membranes while receiving aureomycin and/ 
or chloromycetin. A number of' similar cases including a f'ew cases of' 
fatal genera lized moniliasis were t hen reported by :M:angiaracine (72), 
Gausewitz et al. (45), Woods et al. (137), Vorreith (129) 1 Brown and 
others (14). ~appenfort and Schnall (84) reported in 1951 that aureo-
mycin in vitro could ce.use a definite stimulation of' the growth of c. 
albicans. Later, Seligmann (1141 115) was able to demonstrate that both 
aureomycin and terramycin could enhance the virulence of £• albicans f'or 
mice. Huppert and his associat es - (54) confirmed in vitro the growth 
stimulating effect of' aureomycin, but not terramycin, on £• albicans. 
Recently, McGovern and his col l eagues (77) reported that in a group of' 
45 children given aureomycin or chlor omyoetin orally f'or from 8 to 14 
days the incidence of c. albicans in the gastrointesti nal tract increased 
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- from 17 per cent before the treatment to 33 per cent at the end of the . 
treatment period. Loh and Baker (68) have noted that one subject showed 
a 100-fold increase in yeasts even on as little as 20 mg of aureomycin 
per day by mouth. The subject~ however~ did not show any untoward reac-
tions from the overgrovfch of the yeasts. 
Proteus 
The frequent emergence and overgrowth of Proteus following the oral 
administration of these broad-spectrum antibiotics has been universally 
observed (2~ 7, 12~ 17~ 42~ 57, 76, 81~ 107~ 117~ 138~ 139). Carrere 
and Roux (17) noted in 1951 that 4 guinea pigs given 20 mg of terramycin 
per day for each anilnal developed malnu·crition and cachexia coinciding 
vnth the appearance of Proteus in their feces. Proteus 1vaS also isolated 
from the blood and various internal organs of 2 of the animals after 
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their death. Yow (139) reported in 1952 that 15 cases of urinary infec-
tions, 2 cases of bacteremia~ and one case each of meningitis and peritoni-
tis~ all due to overgrowth of Proteus following oral use of antibiotics~ 
especially the broad-spectrum antibiotics, had been observed during a 2-
year period. Loh and Baker (68) h~ve reported a case who developed a 
dysentery-like diarrhea after receiving aureomycin. Several stool 
cultures from the subject proved the absence of members of either the 
Shigella or Salmonella groups. In fact, cultures made on the usual media 
employed for isolation of enteric pathogens gave pure cultures of Proteus 
on several occasions. .i!bca.7Jlination of his stools for parasites revealed 
nothing. Fortunately~ the symptoms gradually subsided within about 3 
weeks following withdrawal of the aureomycin. These results led to the 
conclusion the.t the diarrhea may have been caused by the overgrowth of 
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aureomycin-resistant .Proteus . I·t; was also because of th9 stimulation 
from these findings that the writer has been greatly interested in 
pursuing the present investigation in the hope of getting a more detailed 
knowledge of the quantitative changes in the fecal flora following oral 
administration of aureomycin as well as looking for more evidence for the 
role of .Proteus in causing dysentery-like diarrhea follovving the medica-
tion. 
Pseudomonas 
The overgrovrth of the drug-re·sistant Pseudomonas during or following 
the oral use of these antibiotics has also been noted by many 1nvestiga-
tors (7, 52, 81, 107). Yow (139) has observed 37 cases of Pseudomonas 
infections, mostly urinary infections during or following the use of 
antibiotics during a 2-year period of clinical experience . Four of tm 
8 illustrative cases presented may have some relation with the oral 
administration of aureomycin. Two of the 4 cases developed pulmonary 
I 
infections and the other 2 developed bacteremia and urinary infections. 
One of these 4 cases died of empyema due to Ps . aeruginosa. 
Conclusion 
A general review of the literature concerning the effects of all 
the commonly used antLmicrobial agents on the normal fecal flora of man, 
l~rer animals, and domestic birds has been presented. Tyrothricin is 
effective chiefly against the Gram-positive flora. Limited experience 
with this antibiotic indicates that it produces no appreciable altere.-
tions of the intestinal flora in mice and may be too toxic for oral 
administration in man. The poorly absorbed sulfonamides are only 
moderately effective and also have the following disadvantages: 
(1) Their action is sl01.'V'e (2) Large doses are necessary. (3) Certain 
intestinal flora such as Pseudomonas~ Proteus 1 yeasts, and enterococci 
are re.fractory to them. (4) 'I'oxicity from the drugs is always a 
possibility. Formosulfathiazole appears to be more effective espcially 
in reducing the number of Proteus, streptococci and clostridia. More 
studies are needed to attain a better evaluation of this drug . 
Penicillin has little or no effect in suppressing the predominating 
Gram-negative flora of the intestinal tract. Streptomycin acts more 
rap i dly and is much more effective against the predominating Gram-
negative flora than the sulfonamides, but unfortunately the rapid 
development of streptomycin-resistance by the Gram-negative organisms 
in the intestinal t~act has greatly limited its usefulness. Neomycin 
possesses a strong and rapid bactericidal activity against a wide 
variety of both Gram-positive and Gram-negative organisms, and has been 
considered by Poth (88) and Riddell (123) as the most effective 
intestinal antiseptic yet discovered. However, it has the disadvantage 
in occasional failure to inhibit tb.e growth of Aerobacter. Bacitracin 
is of little value. · Polymyxin B is very active against many Gram-
negative bacilli, especially Ps. aeruginosa and the streptomycin-
21 
resistant coliforms. Drug-fastness does not occur readily. Unfortunately, 
most Gram-positive organisms, Proteus and yeasts are resistant to this 
agent. Among the broad-spectrum antibiotics ohloromycetin is not 
generally considered to be effective in significantly reducing the 
intestinal flora. Early reports on aureomycin and terramycin indicated 
that these antibiot:i.cs are very effective, becau se they could produce 
rapid reduction of a great variety of the intestinal flora. Conflicting 
reports concerning their real effects soon appeared. The current view 
inclines to believe that these broad-spectrum antibiotics are not suit-
able for preoperative use to suppress the intestinal flora, because the 
medication may actually cause a net increase in the total bacterial 
count due to overgrowth of the insusceptibile Proteus, staphylococci, 
yeasts, Pseudomonas, and enterococci. ruany serious complications as 
a result of this alteration have been illustrated. Combined therapy 
may prove to be more effective than any single component in many 
instances. After all, the ideal antimicrobial agent for preoperative 
use as an intestinal antiseptic is yet to be discovered . 
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MATERIALS AND M.!!:THODS 
Selection of Experimental Subjects 
and Dosage of Medication 
Fourteen normal healthy subjects of both sexes were selected who 
preferably never had received aureomycin or terramycin in the past and 
had not received antimicrobial agents of any kind shortly before the 
investigation. These subjects were each given aureomycin, 250 mg orally 
four times daily (1 g per day) for 5 days. Two of these subjects were 
studied twice. The free interve.l between the 2 courses of medication 
was ~months in one case (W.L.) and 10 days in the other (E.B.) who 
received the medication for 3 days only during his first period of 
investigation. The investigation wns also made on 2 additional aureomycin 
subjects through the courtesy of . Dr. Maxwell Finland of the Boston City 
Hospital. One of these (W.T.J was given 2.5 g of the drug orally daily 
for ~ days and the other (J.P.) 20 mg orally daily for 15 days, then 
1 g intravenously daily for 6 days and finally 1 g orally daily for 6 
days with a free interval of 10 to 14 days betv1een each 2 periods of 
medication. For comparison, three terramycin subjects (V.P., M.P. and 
.. ,._ . ...... . 
R.P.) were also studied through the courtesy of Dr. Henry Bakst of the 
Boston University Medical School. These ware aged 7, 10 and 12 and 
ware each given 200 mg of terramycin orally four times daily for 5 days 
to treat their enterob~asis. 
Bacteriological Studies 
Fecal specimens were stud i ed daily in a great majority of the casas 
for a period of 5 days before medication in order to obtain a basic 
picture of the fecal flora in each case, during the course of medication 
and following the medication for a varying number of days (up to 2Sdays) 
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until ·the fecal flora had returned to normal. The specimens were 
collected in clean wax-coated cardboard containers and were studied 
immediately. If delay was necessary, the specimens were immediately 
refrigerated. A sample totaling one gram was taken from several 
portions of each fecal specimen and was emulsified in 9.0 ml of sterile 
distilled water. The rndxture was then blended into a homogeneous sus-
pension with sterile glass rods. This suspension was diluted in sterile 
distilled water aoco~ding to the technic approved by the A.P.H.A. for 
water analysis (122). The total aerobes were enumerated in pour plates 
of B.B.L. eugonagar ~sing a 1.0-ml inoculum for each plate. The total 
anaerobes (including , facultatives) were enumerated with B.B.L. anaerobic 
agar and Brewer anaerobic culture dishes, using a 0.1-ml inoculum for 
I 
surface streaking. The coliforms were enumerated in Difco Violet Red 
~le Agar using a o.5 ml or 1.0 ml inoculum for making pour plates. 
'rhe yeasts were enumerated on grape juice agar using 0.2 ml. inocula. for 
surface streaking. The grape juice agar was prepared by suspending 40 g 
of Difoo Bacto-Aga.r in 750 ml of distilled water to tvhioh 250 ml of 
commercial grape juice had been added. This was then mixed thoroughly 
and boiled gently for 3 to 5 minutes, cooled and poured into Petri 
dishes. The medium contains approx~nately 5 per cent of sugar and 4 per 
cent of agar, and has a final pH about 3.9. In the writer's experience, 
it exerts no inhibition on the growth of yeasts an~a.ppears to be very 
selective, allowing only the growth of yeasts and other fungi probably 
due to its low pH. The staphylococci were enumerated on Difco ~taphylo-
coccus Medium using 0.2 ml inoculum for surface streaking, and the 
organisms so obtained were confirmed each time with Gram stain smear and 
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catalase test. Representative strains of Staphylococcus aureus were 
saved for cultural tests for pathogenicity. §treptococcus faecalis was 
detected using Difco S F Medium containing sodium azide. Five tubes of 
the liquid medium were inoculated with each appropriate dilution and 
incubated at 45.5 C for 48 hours. When no growth occurred in any of the 
tubes after two days' incubation, the tubes were re-incuba.ted for an 
additional 24 hours. From the number of positive tubes, the most probable 
number of Str. faecalis in each specimen was determined from the tables of 
Prescott (100). ~6j:!1;1:S and _Pseudomonas, when present, were enumerated on 
I 
Difco SS Medium using 0.2 ml inoculum for surface streaking. All the 
plates were incubated aerobically at 37 C for 48 hours, followed by 24 
hours' incubation at r .oom temperature before final counting. The coliforms 
were usually counted at the end of the first 24 hours' incubation and the 
total anaerobes enumerated at the end of 48 hours' incubation. All the 
plates mentioned above were made in duplicate and the final count for each 
kind of organism is ~n average of the numbers obtained from every 2 
plate.s. The oounting was sometimes done with the aid of a hand magnifying 
lens, especially ?men the colonies were too small to be identified with 
naked eye. 
No further identifications of the tote.l aerobes, the total anaerobes 
and the coliforms were intended. However, the coliforms from the last 4 
aureomycin subjects (A.P., A.C., K.C. and T.S.) have been identified and 
tested for their sensitivities toward aureomycin as a part of a separate 
research project (126). The results will not appear in this report. The 
yeasts were further studied for the presence of pseudomycelia and chlamydo-
25 
spores in corn meal agar (18) after 3-7 days' incubation at room temperature. 
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The _strains of the Staph. aureus were further studied for their ability 
to produce coagulase as well as to hemolyze blood. Str. faecalis was 
sometimes studied with Gram stain smear for its purity but no further 
identification was conducted. Proteus was first transferred to Kligler 
Iron Agar for observ~tion on its abi lity to swarm and its preliminary 
sugar reactions. The species of the organismwas then identified accord-
ing to the following criteria, modified after Proem and Woiwood (98') : 
Fermentation of 
Glucose Lact. Mannitol Maltose 
Prod. of' Urea 
Species Sucrose Indole H2S Reaction 
P. vulgaris AG 
-
AG AG f 
P. mirabilis AG AG (late 
or neg.) 
P . morganii AG f 
P. rettgeri* A A A (late f 
or neg.) 
*This species should be excluded from the genus 
because of its inability to produce amines. 
A---acid; G---gas. 
f rapid 
f rapid 
I slow 
I rapid 
Proteus, -.;:....;;.....;....;;....;.~ 
All the bacterial counts were converted into numbers of organisms 
per gram of wet feces. The Logarithms of the numbers were finally plotted 
against time as the abscissa. The curves for each kind of organism were 
then divided into groups according to the patterns of alterations. Tabu-
lation of results was done wherever indicated. 
Serological Studies 
Blood samples were taken before the administration of aureomycin and 
at intervals after cessation of the therapy in case of overgrowth of 
Pro·t;eus. The sera in each case ware then test;ed against one strain of the 
organism isolated from the same subject during the peak of the overgrowth 
of the organism, using the usual tube technic for 11 011 agglutination test. 
- The .antigen was prepared by boiling a water suspension o£ the organism 
£or one hour. The titers o£ the agglutination were read usually after 
18 hours' incubation at 50 C in a water bath. 
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RESULTS 
Bacteriological Studies 
A definite alteration in fecal flora was observed in all the cases 
following medication. Aureomycin and terramycin behaved in a similar 
manner, therefore the results for both drugs will be presented together. 
The data on the daily bacterial counts for eaoh subject are presented as 
graphs (Figures 4 to 23). The duration of alterations in feoa.l flora is 
sunm~rized in Table 1. 
In one subject (J.P.) the intravenous administration of aureomycin 
seems to have caused less alteration i n the fecal flora than the oral 
administration of the drug in the same daily dose. Observations on this 
single oase do not permit any conclusions regarding differences due to 
routes of administration of the drug. In the same case, 20 mg of aureo-
mycin orally per day for 15 days produced no appreciable alteration in 
the fecal flora except for a 100-fold increase in yeasts. The increase 
in numbers started on the second day, reached its peak on the 12th day 
of medication, and then the number of yeasts gradually decreased to the 
pre-drug level 5 days following discontinuance of the medication. 
As to the degree of alteration due to difference in dosage of medi-
cation, again no definite conclusion can be drawn between the changes 
produced· in subject Vi .T. given 2.5 g of aureomycin orally per day for 8~ 
days and the other subjects given only one gram of aureomycin orally per 
day for 5 days. Generally the pattern of alterations in the fecal flora 
varies considerably from subject to subject as well as from organism to 
organism. The data presented below will tend to show the common patterns 
for each group of organisms studied. Some of the results of this 
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I 
investigation have been previously reported (68). 
1. Coliforms& In tHis investigation the term "Coliform" includes all 
laotose fermenting Enterobacteriaceae. The alteration in number of coli-
1 
form organisms during and following medication is summarized in Table 2. 
The patterns of alte~ation are illustrated in Figure 1. 
! Figure 1 
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Figure I. 
PATTERNS OF ALTERATION IN COLIFORMS 
MEDICATION 
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X···· · X A.K. - , 3 
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The curves in Figure 1 represent data obtained from individual 
subjects but similar data were obtained for other subjects. The pattern 
of alteration generally notGd in 14 subjects was a decrease in numbers 
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quickly followed by an increase in coliforms. The maximal decrease 
usually occurred on the second or third day following the start of the 
medication (in about 60 per cent of cases). The maximal increase in 
population following the initial decrease occurred in a period from 2 to 
21 days following discontinuance of medication. The average was about 6 
days. Several minor variations in the pattern were also noted. 
Two subjects (A.B., H. B.) showed a late maximal decrea'se which 
occurred after the medication had been discontinued in contrast to the 
early maximal decrease which occurred during medication in all the other 
cases. Four subjects (M.P., W.L.-II, M.s., J.B.) showed increases in 
numbers of coliforms to well above the pre-drug levels. The other 8 
subjects showed increases in numbers of coliforms only to the pre-drug 
levels. 
Another pattern of alteration was noted in 3 subjects (A.K., M.c •• 
V • .P.J in whom there was no appreciable change in coliform population 
throughout the c.ourse of study. 
In one subject (K.C.) the medication resulted in complete dis-
appearance of coliforms from stool cultures. These data are listed 
separately because similar observations have been reported by other 
investigators (20, 21, 78, 82). 
It required a period of from 0 to 15 days (average about 5 days) 
following discontinuance of the medication for the numbers of coliform 
to return to their pre-drug levels. 
2. Total aerobes and total anaerobes: The term 11total aerobes" includes 
all organisms culturable on B.B.L. eugon-agar and in the case of 
"Anaerobes 11 includes all organisms culturable on B.B.L. anaerobic agar. 
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Generally these groups of organisms seem to follow the same patterns as ' 
do the coliforms. The decreases in numbers of both aerobes and anaerobes 
during medication were often much less marked and in no case were they 
elL"llinated completely. Clear-cut exceptions were noted in 2 subjects 
(T.S., D.L.) in whom the numbers of coliforms decreased while the numbers 
of total aerobes and total anaerobes showed only slight changes. 
Periods of from 0 to 17 days following discontinuance of the medica-
tion were required for the numbers of total aerobes and total anaerobes to 
return to their pre-drug levels. The average was about 7 days. 
3. Yeasts: Yeasts were found in 11 subjects or in approximately 60 per 
cent of the cases studied. 142 representative strains isolated from these 
11 subjects were further studied on corn meal agar. Strains developing 
both pseudomycelia and chlamydospores on this medium are generally considered 
to be Candida albicans (18) • On this basis 109 strains ( 77 per cent) were 
considered to be c. albicans. Only £• albicans was isolated from 6 of the 
11 subjects in whom yeasts had been found. The other 5 subjects had c. 
albicans and other unidentified yeasts. 
In most ins-Bances, the yeasts showed a rapid 100-fold to 1~000-fold 
increase without undergoing any initial decrease in population during 
medication. A period from 0 to more than 15 days after the medication 
had been discontinued, with an average of 7.5 days, was required for the 
counts to return to their pre-drug levels. Four subjects (V.P., M.S., 
R.P., A.C.) who did not have detectable yeasts before medication showed 
the presence of and proliferation of yeasts during and following medication. 
Two subjects (E.B., R.M.) showed fluctuations but no significant increase 
in the yeast populations during and follo,ring the medication. The other 9 
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subjects all showed definite increases in numbers of yeasts in response 
to the medication. 
4. Staphylococci: Staphylococci were studied in the feces of 18 subjects. 
Their responses to medication were~ in general~ less uniform than in the 
case of the other organisms studied. However, 3 major patterns of altera-
tion were observed and are illustrated in Figure 2. 
Figure 2 
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A pattern of alteration was noted in 3 subjects (H.B., A.B., V.P.) 
in whom the decrease or disappearance of staphylococci due to medication 
was quickly followed by an increase in the population up to or above pre-
drug levels. There was a complete disappearance of the staphylococci 
while receiving medicati on in two of these subjects (H. B., A. B.). The 
other subject (V.P .J showed only a small decrease in numbers of staphylo-
cocci during medication. 
In three subjects (A.?., K.C., D.L.J there were some fluctuati ons 
but no significant alterations in staphylococcal populati ons due to 
medication. 
A 100-fold to 1,000-fold increase without any initial decrease in 
population due to medication was noted in 12 subjects (67 per cent of 
cases). Half of these subjects showed maximal increases in staphylococci 
during medication, and the other hal£ showed maximal increases following 
discontinuance of the medication. 
It took a period of from 2 to 15 days, or slightly longer, following 
cessation of medication for the number of staphylococci to return to their 
pre-drug levels for all subjects who had an i ncrease in staphylococci. 
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Seven subjects (39 per cent) harbored staphylococci with golden-
yellow colonies. Two of these subjects did not have su~h organisms until 
medication. In one case (J.P.) they were found during medication and in 
the other (M.C. ) after discontinuation of medication. The other 5 subjects 
all showed the presence of golden-yellow staphylococci during the pre-drug 
period. Further study of representative strains isolated from the 7 
subjects showed that the staphylococci i solated from 2 subjects (M. s ., 
M.C.J were coagulase-negat ive but those isolated from the other 5 (M.P., 
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y•i:'- ·~ W.L.-II~ J.B., K.C.) were hemolytic, coagulase-positive and mannitol-
fermenting. 
During medication there was an interesting shift between the staphylo'7' 
coeci with golden-yellow colonies and t he staphylococci with white colonies 
noticed in 4 subjects (M.S., J.B., W.L. ·-II and K.C~) receiving aureomycin 
and one subject (M.P.) receiving terramycin. The staphylococci with 
golden-yellow colonies were totally replaced by staphylococci with white 
colonies. In three subjects (M~ •• M.S., w.L.-II) the latter proliferated 
rapidly towards the end of the medicatii::>n period, and with cessation of' 
medication, the staphylocoeci with gold•3n-yellow colonies re-appeared at 
the time the population of the staphylo•3occi with white colonies had 
started to decline. In another subject (J.B.) the staphylococci with 
golden-yellow· colonies did not return f(>r as long as 7 days following 
discontinuance of' the medication (f'urth•3r fecal samples were not available). 
Complications due to staphylococc:i did not develop in any of the 
subjects studied. 
5 . Streptococcus f'aecalis: Organis.ms which grew in Difco S F i'l.edium 
were considered to be Str. faece.lis. Further studies of occasional 
cultures gave results consistent with a diagnosis of ~tr. faecalis. The 
numbers of Str. faecalis were follmved in twelve subjects who received 
aureomycin. Several patterns of alteration were noted. 
Figure 3 
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In 8 subjects there was an increase of 100-fold to 10.000-fold in 
population without an initie.l decrease during; medication. Four of these 
subjects (A.K., D.L., T.S., J.P.) had a maximal increase during medica-
tion and the other 4 subjects (A.C., J.B., K. C., A.B.) showed me.xims.l 
increase in about 2 to 8 days following; discontinuanc~ of the medication. 
Three subjects (A.P • ., w·.L.-II, M.S.) showed only insignificant 
fluctuations in the numbers of ~· faecalis throughout the whole course 
of study. 
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~· faecs.lis disappeared completely from the feces of one subject 
(H.B.) shortly following medication. 
It took from 0 to 17 days for the numbers of~· faeoalis to 
return to their initial pre-drug levels following cessation of the 
medication. The average was about 5 days. 
6. Proteus: In this study all non-lactose fermenting colonies having 
black centers on SS Medium were considered to be Proteus. Representative 
colonies were specifically identified. P. mirabilis was found in 10 of 
the 19 subjects studied. No other species of .Proteus was encountered. 
Nine subjects receiving aureomycin, from whom Proteus could not be 
isolated before medication, shovred the presence of' P. mirabilis on the 
second or third day of medication. In another subject receiving aureo-
mycin, who was a P. mirabilis carrier, this organimn disappeared on the 
- -- ·-
fourth day of medication, followed by a re-appearance and a marked rise 
in numbers to above the initial pre-drug level. In almost all cases 
rapid proliferation of this organism· to over 107 organisms per gram of 
wet feces was noticed vli thin four days follovring the appearance or re-
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appearance of the organism. It took a period of from 6 to 25 days follow-
ing cessation of medication for the organism to disappear or to return to 
its initial pre-drug level. 
7, Pseudomonas aeruginosa: The stools of one subject receiving aureo-
myoin showed the presence of Pseudomonas on the third day of' medication. 
It increased in numbers to 106 organisms per gram of wet feces in 2 days, 
then began to decrease, and disappeared 5 days following cessation of 
medica.tion. No ill effects from the rapid prolif'eration of' this organism 
were observed. This species was not recovered from the stools of any 
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o,;ther subjects. 
Serological Studies 
Most investigators consider that an infection leads to a rise in 
the titer of antibodies directed against the infecting agent. In order 
to determine whether or not the marked increase in numbem of Proteus in 
the stools of some of the subjects is accompanied by infection, serological 
studies of such persons were conducted. Agglutination : tests were carried 
fl.,. 
out on the sertUJ. of 9 subjects all of whom showed marked alterations in 
numbers of fecal Proteus due to medication. Sera collected before and 
after treatment from each subject were employed. Only 2 subjects (M.S. 
and T.S.) showed increases in agglutination titers and these were slight. 
Sera collected from one subject (M.S.) showed a rise in the titer from 0 
to 1:8 on the lOth post-drug day and 12 days followiug appearance of 
Proteus in his feces. The titer dropped to 1:4 on the 29th post-drug 
day and 15 days following disappearance of Proteus from his feces. This 
subject showed no clinical evidence of infection v-Ii th Proteus. Serum 
from the other subject (T.S.J had a titer of 1'4 on the second day follow-
ing appearance of Proteus in her feces while receiving medication. A 
control specimen of serum taken before medication was unfortunately not 
available. Three days following the appearance of Proteus in the feces 
she started to have symptoms of Proteus urethritis which lasted for about 
10 days. The agglutinin titer of her serum increased to 1~6, 6 days 
follovting disappearance of Proteus from her feces and 18 days before dis-
appearance of Proteus from her urine and urethral cultures. Sera from 
the remaining 7 subjects did not show the presence of detectable anti-
body at any time. 
Untoward Reactions and Bacterial Complications 
Following Medication 
In general, the dosages of the drugs used were well tolerated. 
Stools, during and in~ediately following the medication, were gen~rally 
bulky in quantity and loose in texture as described by Bro~n (15) 
and Rivera and Sborov (107). Approximately 75 per cent of subjects 
experienced "gas distension" and some increased frequency of bowel move-
ments. These symptoms usually started from one to three days after 
initiating medication and persisted as long as 2 days following cessation 
of the medication. At no time was watery or bloody diarrhea noticed. 
During medication impaired appetite was complt:dned of by 6 subjects, 
general weakness by 3 subjects, mild nausea by 3 subjects and some feeling 
of "motion-sickness" by one subject. 'l.'wo and one-half gm of aureomycin 
per day given to one subject (W.T.) seemed to cause more nausea than a 
smaller dosage. 
Rapid proliferation of Proteus, staphylococci, yeasts, Pseudomonas 
or other organisms were not associated with diarrhea or disseminated 
infections in any subjects studied. One female subject (T.S.), hmvever, 
developed symptoms of urethritis during the time of rapid proliferation of 
P. mirabilis. The symptoms started 4 days after initiating aureomycin 
therapy and 3 days following the appearance of Proteus in her stools, 
almost coinciding with the time of maximal increase in fecal Proteus 
population. P. mirabilis, identical with the Proteus in her feces, was 
repeatedly isolated and was the predonunant organism in the urethral dis-
charge and first portions of her urine specimens. The organism was found 
to be completely resistant to aureomycin, but somevrhat sensitive to 
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·streptomycin on disc-sensitivity test. The symptoms lasted for about 1~ 
days, but the organism did not disappear from her urine and urethral 
cultures until the 33rd post-drug day and 24 days following disappearance 
of Proteus from her feces. She received 8 grams of gantrisin, 1.6 million 
units of penicillin and 2 grams of dihydro-streptomycin during a 2 days' 
period 4 days after the complication had started. 
DISCUSS IOU 
It is evident from the results obtained in the present study that 
the pattern of alteration of the fecal flora of normal humans varies 
considerably from subject to subject and from organism to organism. 
Predictions cannot be made with certainty. Generally speaking, the 
alteration of _the fecal flora during oral administration of aureomycin 
or terramycin as reported here are less marked than those reported by 
other investigators. This may, in part, be a reflection of a general 
trend in the direction of increased antibiotic resistance of the normal 
flora of hQ~ns as a result of the widespread use of antimicrobial 
agents (33, 38, 69). · It is not the purpose of this presentation to 
give the impression that broad-spectrum antibiotics have no value what-
soever for pre-operative use as a means of producing intestinal anti-
sepsis. One should, however, be aware of the possible complications 
and consequently understand the lL~itations in the use of these drugs. 
For instance, the secondary increase of some organisms during medication 
as reported here would indicate the need for a relatively short over-all 
course of medication. With the dosage used in this investigation, the 
maximum effect of the antibiotics might be expected only during the 
first 2 to 3 days of medication and one may possibly obtain an adverse 
effect beyond that time. 
The increase in numbers of coliforms, total aerobes and total 
anaerobes during the medication, with or without an initial decrease in 
numbers found in this study agrees well with some of the findings of 
Ganey at: al.(42), :Morton et aL (81)., Tyson et aL ~7) Allen (2). , 
However., more detailed data have been obtained in the present investiga-
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tion. Similar increases in numbers of these organisms have been pre-
viously reported by many other investigators (28 1 31, 43, 120) in 
studies of streptomycin and su1fonamides. The appearance and rapid 
increase in numbers of A. aerogenes to replace the sensitive strains 
of E. coli during medication as found in two (A.P. 1 K.C.) of the four 
subjects of this series in a separate study (126) may be a factor to 
explain the secondary increase of the coliforms. The persistence of 
Aerobacter during medication had been previously observed by Sborov 
and his associates (111) in patients during treatment with aureomycin 
and by Spaulding and his associates (120) during treatment with strep-
tomycin and sulfatha1idine. The increase in numbers of coliforms is 
usually reflected in a similar increase in total aerobes and anaerobes 
(including facultatives) of which the coliforms form a major portion. 
Exception to this is quite evident in at least one subject (T.S.) whose 
coliforms showed a decrease toward the end of the medication while the 
number of her total aerobes and total anaerobes showed increases due 
to rapid proliferation of Proteus to above the coliform populati~n. 
The increase of staphylococci, yeasts, ~· faecalis and Pseudo-
monas as reported here is in agreement with practically all of the recent 
reports in the literature concerning the effects of these two antibiotics. 
An obvious difference in this investigation, however 1 would be the 
absence of serious complications due to these organisms in contrast to 
a number of cases of staphylococcic diarrhea, moniliasis and procto-
colitis reported by many other invest;igators (22• 45, 49 , 63, 139). 
The absence of serious complications here could be partly due to the 
srooll doses and short duration of the medication and partly due to high 
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resistance or the excellent nutritional status of the healthy subjects 
studied. 
'rhe growth of yeasts seems to be stimulated by the medication in 
a great majority of the cases either directly or indirectly through 
suppression of other organisms. 'fhe direct grovvth sti...l!lUlating effect 
of aureomycin has been demonstrated recently ~ vitro by Pappenfort et 
ale (84) and Huppert and his associates . (54) and the factor responsible 
for this stimulation cannot be identified with the antibiotic activity 
of the drug. The incidence of c. albicans in feces as reported here 
appears to be 2 to 4 times higher than the figures in the literature 
(77. 123). 
The incidence of Proteus in feces has increased from about 5 per 
cent before medication to about 50 per cent following medication . The 
former figure is still comparable to tl1e 10 per cent incidence found 
by Rustigian and Stuart (110) who used direct plating of fecal specimens. 
The 50 per cent figure is certainl y unusually high possibly due to a 
grov~h sti...mulation by the medication either directly or indirectly 
tl~ough the suppression of other organisms. Of all the micro-organisms 
studied in this investigation, Proteus seemed to react most profoundly 
to the medication with a rapid and marked increase in population. These 
organisms did not disappear or return to their initial pre-drug level 
until from 6 to 25 days after the cessation of the medication. Despite 
the changes noted in 10 of the 19 subjects studied, i1o evidence whatso-
ever has been obtained to suggest that a marked increase in numbers of 
Broteus might be responsible for ·a dysentery-like diarrhea. T •• is the 
only female subject who experienced a considerable increase in numbers 
of ·Proteus in feces due to medication and also happened to be the only 
case of complication (urethritis) due to Proteus in this series. The 9 
male subjects carrying Proteus developed no such complication under the 
same or similar circumstances. 1'his discrepancy may be at least partly 
due to anatomical differences beti'reen the two sexes, since the external 
urethral orifice is located closer to the anal region and consequently 
is subjected to greater risk of fecal contamination in females than in 
males. Of course, difference in personal hygiene could be !mother factor 
in that regard. This experience indicates the need for a caref ul watch 
and prompt institution of suitable preventive measures for such complica-
tions in case of a marke d increase of Proteus 1 especially in females. 
It is, therefore, suggested that in case of females Proteus should be 
watched for in the feces by carefu l routine stool cultures at least every 
other day during and shortly following medication . This routine stool 
culture can elso provide information concerning alterations in other 
organisms. 
The overgro-wth of Proteus seemed to exert varyhlg degrees of 
suppress ion on coliforms in 2 subjects (A.B., T. S.), on staphylococci in 
3 sub jects (T. S., A.P., lN.T.J and on~· faecalis in 2 subjects (W.L.-II, 
A.B.). These organisms showed an actual decrease or at least a suspension 
of their original tendency to increase while Proteus f lourished. They 
returned to their original nun~ers after the Proteus had started to de-
cline. Whether or not this is a matter of specific microbial antagonism 
or only the result of simple suppres s ion due to overgrov~h of one organism 
over the other remains to ,. be investigated . 
The increases i n agglutinin titers in the sera of two subjects ('M.S. 
and T. S.) suggest the possibility of Proteus infections. Infection, if 
any, in M. S. wa.s subclinical in nature, whereas the urethritis in T.S. 
was clinically obvious. In the remain ing 7 Proteus-carrying subjects 
studied serologically, the failure to develop an antibody response as 
demonstrated by agglutination tests may, at leas t , in pe.rt, be due to 
the lack of invasiveness of the organism and the resulting insufficient 
antigenic stimulation. 
There ar e many reports in the literature which are in disagreement 
with t he data presented here concerning changes in the fec al flora. of 
man. Several factors may be responsible for these diff erence s of 
opini on. Some of these are: 
1. Difference in dosage of the antimicrobial agents used: Rivera. and 
Sborov (107) and :McVay (78) have clearly demonstrated that greater 
therapeutic doses can produce greater suppression of the intestinal 
flora than the smaller doses of the same antibiotic under the same 
experimental condition. 
2. Difference in level of the intestinal tract where the f lora wer e 
isolated and studied: Again in I/f.cVay' s investigation (78) comparing 
the effects of aureomycin on fecal flora e.nd on intestinal flora 
isolated through cecostomy and colostomy wounds, it is evident that 
organ isms compri sing the intestinal flora. from higher levels were 
suppressed earlier and to a greater extent than those present in 
feces. This view is supported by the findings of Johansson et a.l. 
(60). 
3. Use of adjuvant pre-operat ive measures such as colonic irrigation, 
cathar sis, and low residue diet to reduce the population of intestinal 
flora. 
4. Difference in technic: ·ro illustrate, the writer is in entire agree-
ment with l'J etzger and his associates {75) who have expressed the 
opinion that discrepant results may be obtained with a simpli£ied 
streak plate technic as compared with the serial dilution-pour plate 
technic. It is also the •vriter's experience that by using technics 
and media different from those of Dr. T. :M. Gocke of the Boston City 
Hospital for daily study of the same fecal suspensions (10-l dilution) 
from the se.me test tubes, the results obt~ined were different . from 
those of Dr. Gocke. Nevertheless, the general trends of alteration 
obtained by the two groups of investigators e.gree fairly v;ell for a 
great majority of the flora studied. 
5. Differences in response of the host as clinically observed, in degrees 
of sensitivity of the intestinal flora to the antimicrobial agent and 
in the environment: Morton and his associates (in) have clearly 
pointed out that bacteriological evidence does not always confirm the 
clinical results. The degree of sensitivity is not only an inherent 
fe.ctor of the intestinal flora itself, but could also be modified by 
any previous medications given to the host. In regard to the environ-
ment, any factor such as drug or concomitant infection capable of 
altering the thermodynamic environment and culture medium in the 
intestinal tract would complicate the alterations of the fecal flora. 
SUNMARY 
1. The alterations in fecal flora in 19 normal subjects, 16 of whom re-
ceived aureomycin and 3 of whom received terramycin are described. 
2. Generally, the responses of' the fecal flora to medication vary con-
siderably from subject to subject as well as from organismto organ-
ism. The responses of each group of fecal organisms are analyzed 
and a few representative patterns of alterations are illustrated in 
cases of coliforms, staphylococci and Str. faecalis. In the majority 
of cases, the coliforms, total aerobes and total anaerobes seemed to 
follow a similar course of alteration----decrease followed by a second-
ary increase in population during medication. Yeasts and ~roteus were 
generally stimulated by the medication. Proteus seemed to give the 
most marked and persistent alteration. The staphylococci and Str. 
faecalis, in general, responded to medication in a less uniform manner. 
3. Ora~ administration of these antibiotics by no means renders the intes-
tinal tract sterile. The time limit for achieving a maximal-effect 
from the administration of broad-spectrum antibiotics is stressed. 
4. There is no evidence that a marked rise of Proteus causes a dysentery-
like diarrhea.. The only significant complication following medication 
noted in this investigation was the development of Proteus urethritis 
in one female subject. 
5. Agglutination tests for Proteus were carried out in nine subjects who 
showed extensive grovvth of Proteus in their feces due to medication. 
Two of these subjects showed increases in agglutinin titers. The re-
maining 7 subjects failed to show such increases. Possible explanation 
for this failure is given. 
6. Some important factors contributing to the conflicting reports in the 
literature on the effect of these antimicrobial agents are discussed. 
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~PPENDIX 
TABLE 1 
Durations of A-lterations in Fecal Flora Following Medication 
No. Subjects Approximate Number of Days Required by The Organisms to Re-
turn to Their Pre- drug Levels Following Cessation of Medica-
tion 
coliforms total aerobes yeasts total Proteus 
1 W.L.-I NS** 
2 E.B.-II NS 
3 W.T. 0 
4 V .P .i~ 7 
5 M .P.~~ )13 
6 R.P .~i- 0 
7 R.M. 0 
8 J .P.-III 3 
9 A.B . 8 
10 H.B. 3 
11 M.s. 10 
12 \'f .L .. -II 4 
13 J.B. 7 
14 M.C .. 15 
15 D.L. 0 
16 A.K. 8 
17 A.P .. 0 
18 A.C. 0 
19 K.c. 3 
20 T.s. 3 
Range 0 to 15, 
*terramycin subjects. 
~"* NS--not studied. 
and t otal · staph. 
anaerobes 
17 6 NS 
1 0 NS 
0 >3 >3~-:!-* 
13 4~~*"~ 10 
>13 )13 >13 
7 . >12-lH~* 10 
1 0 5 
5 > 5 5 
10 8 2 25*l<* 
3 12 19 
10 ) 15-l<--l<* 10 15R-l:-
4 6 10 6*** 
7 0 5 / 
>15 )15 15~!}-~~} 
0 0 9-:t-::-* 
8 11 17-l-'->':-* 
0 0 19~<* 
6 12*** 5 
6 0 
7 4 ~!-** 
0 to 17, 0 to >15, 0- >15, 6-25, 
~~~organisms appeared during or following the medication. 
- not found ; 
Ps. Str. 
faecalis 
NS 
NS 
NS 
NS 
NS 
NS 
5-:H!* NS 
3 
17 
7 
1 
1 
5 
NS 
6 
0 
-
0 
>12 
4 
>7 5, 0 to 17 
E.B.- I (treated with aureomycin for 3 days only), J .P.-I (tr eated with 
20 mg of aureomycin daily) and J .P.-II (treated with aureomycin intravenously) 
are not included in the above table. 
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TABLE 2 
Alterations in Coliforms During and Following Medication 
NO. Subjects Ra.n~e of :C.owest Counts Highest Counts · 
Pre-drug Counts* Count* When(Day) Followin~ the Decrease 
When ~De.:Yl Count* 
1 W.L.-I Not studied 
2 E.B.-II Not studied 
5.0xl03 2.3xl08 3 W.T. 6.9xl08 7 2 
4 V.P.** l~lxl07 to 3.7xl0 ·No gecree.se 
5 M.P.** 5.0xl05 to 2.0Xl06 9.0:x10 2 1.4xl09 
6 R.P.** 7.ox1o6 to 3.8xlo7 6~0xl03 3 1.2x108 
7 R.M. 3.1xl06 to l.lxlos 1.6xlo4 3 7.2xlo7 
8 J.P.-III 1.1x106 to 1.6:x1o6 s.ox1o3 3 5.5xlo5 
9 A.B •. 1.2x1o7 to 5.4xlo7 4.2:x1o4 i~!~ 4.6x1o7 10 H.B. 4.0x106 to 3.7:x1o7 9.0:xlo3 1.9xl08 
11 M.s. 4.0x106 to 1.7x1o7 1.0x105 2 1.sx1os 
12 W.L.-II s.2x106 to 1.8x1o7 7.0xl04 2 3.0x1o8 
13 J.B. 1.5x1o5 to 9.0xlo5 1.1x1o4 2 5.ex1o7 
14 M.C. 9.0x1o5 to 5.3xlo6 1.5x1o5 1 2.sx1o8 
15 D.L. 2.0xl07 to 2.8x108 8.0x104 5 2.5x107 
16 A.K. 5~4xl06 to 1.2xl07 6.4x105 2 1.7x108 
17 A.P. a.2x1os to 1.0x1o7 9e4x103 3 1.9x1o7 
18 A.c. 1.3x106 to 5.9x106 9.0x102 2 1.7x1o7 
19 K.C. s.Ox105 to 3.0xlo7 Not found 4 to -1(A)2.5x1o8 
2.1x106 to 2.lxl07 4.4xl04 4 4.8x107 20 T.s. 
* Count - number of co1iforms per gram of wet feces 
** Terramycin subjects 
· (A) After cessation .of the medication 
6 
. B(A) 
iJ!~ 
l~!!l 
~~!~ 
3(A) 
~!!l 
2
H!l 
4(A) 
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.TABLE 3 
Agglutination Tests for Proteus 
Subjects Sera tested Strains of Proteus A~~lutinin titers 
Tested 
1:2 1:4 1:8 1:16 1:32 
A.B. AB-4-27(8) AB-4-30(P) 0 0 0 0 0 
A.B. AB-5-14~S~ n 0 0 Q 0 0 It AB-5-29 S 
" 
0 0 0 0 0 
H.B •. HB-4-28(8) HB-4-23(P) 0 0 0 0 0 
" 
HB-5-13(8) It 0 0 0 0 0 
It HB-5-29(8) 
" 
0 0 0 0 0 
M.s. MS-4-28(8) MS-5-4(P) 0 0 0 0 0 
" 
MS-5-13(8) " lA A I 0 0 
,.fl MS-6-l(S) " 0 0 0 W.L.-II WL-8-4 S WL-8-15 P 0 0 0 
It WL-8-18(8) " 0 0 0 
· fl WL-10-13(8) It 0 0 0 
D.L. DL-9-3(S) ~DL-9-7~Pj 0 0 0 0 0 0 0 0 
: II DL-9-17(8) DL-~-9 P 0 0 0 0 
M.C. MC-8-29(8) MC-9-9(P) 0 0 0 0 
,,, MC-9-19(8) 
" 
0 0 0 0 
A.K. AK-9-24(8) AK-9-23(P) 0 0 0 0 
'" 
AIC-9-30(S) " 0 0 0 0 A~P. AP-10-l3(S) AP-10-16(P) 0 0 0 0 
: 11 
-
AP-ll-4 {8 n 0 0 0 0 
T.8. T8-ll-23 S TS-11-30 0 0 0 
TS-12-7 ~ ~ 0 · 0 0 " TS-12-9(S) { " ~ I 0 ,!- 0 
The positive tubes were recorded as I , I, If, ,ill, 1111 according to the 
degree of agglutination. o--no agglutination. 
The numbers used to name the strains of Proteus and sera designate the 
month and the day on ~ich Proteus was isolated or the serum was collected. 
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Keys to Figures 4 to 23 
A--••---• •--fl-•·---• •--ATotal anaerobes 
.t&.---------'liAk--------_.A~Total aerobes 
X-·- ·--·-. X- ~-xcoliforms 
0...,.__ ________ ~0)----------® Total staphylococci 
()~--------~()T--~--------~()Staphylococci (white colony) 
••~---------4et--___; _______ _.. Staphylococci (golden 
yellow colony) 
A--•- •--•--A-- • --•- •---AYeasts 
0 • • • • • • • • 0 • • • • •· • • 0 Streptococcus faecalis 
• _ ._ _____ e- _____ • Proteus mirabilis 
@)- --- -- ____ ® ____ -@Pseudomonas aeruginosa 
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Conflicting reporta have appeared conceming the ability of broad-
spectrua antibiotics to reduce the population at the intestinal .flora. 
The purpoae ot thia investigation has been to study in detail the alter-
ationa in .fecal .flora .following oral administration at aureamJein 
(chlortetracycline) w1 th the hope or attaining a better understanding or 
the changes. 
Ntn.teen norul yCJ~mg adults were each giwn either aureC~~~~yein or 
terramycin, 250 q, orall7 4 ti•• dail7 tor 5 da711 in a great 1111jori ty 
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. or the cases. · In bacteriological atudiea, .fecal apeciaena were atudied 
dail7 tor a period ot 5 da71 before Mdication, during the tiw dl:ra• 
courH or aedicatiaa. and tollowiftl the Mdication until the fecal .flora 
had returned to pre-drug leTela. A sample totaling one grn na taken 
from HTeral porticm;a or each fecal apecimen, blended into a ha.ogeneoua 
au.spenaioo in 9.0 Ill of sterile diatilled w~ter, and diluted nriall7 in 
aterile distilled water. The total aerobe• were enuaerated in pour platea 
at B.B.L. eugoaagar. ,The total anaerobe• (includina facultatiws) wre 
counted w1 th B.B.L. anaerobic agar and Brewer anaerobic culture diahes. 
The eolitoru were enu.erated in pour plate• ot Ditco Violet Red Bile 
Agar. The :reaata were counted on grape juice agar. The nWDbera ot 
ataphylococci were dete!'lli.ned on Dileo Staph:rlococcua Vediua and the 
organi ... obtained were tentatively identitied by Graa stain and CatalaH 
teat. Streptococcua taecalis waa counted in Ditco S F ediWI. The tubes 
ot broth wre incubated at 45.5 c. tor 48 hours and the aoat probable 
nWiber ot ~· raecalis in each speciaen was then determined trc:a the 
table• of Prescott. Proteus and Paeudo.onaa, when present, were enu.arated 
aa Di.fco ss med1U11. All cul tuna were incubated aerobicall7 at n c • .for 
- 1 
u8 hours, followed b7 24 hour•' incubation at room temperature. The 
coliforma were uauall7 counted at the end of the tirat 24 houra• 
incubation. Total aerobea, total anaerobe• and colitonaa were not 
identified further. The yea•ts were further studied in corn •al agar 
tor the rorution ot paeudCBl'Celia and chla1Q'doaporea. Repreaentltive 
strains ot Staphrlococcua aureue were •tudied for · their abili t7 to produce 
coagulau and to h .. ol;rse blood. Strains ot Proteus wre identified 
~re. 
eul turall7• In aerologieal atudiea, blood eaaplea 11 taken before 
aedication and at intervale following medicatioo it Proteua •• preMnt. 
The aera in each ease were tteeted for agglutination againat one atrain 
ot the organia iaolated frOIIl the aa• aubject. 
A definite alteration in the fecal flora was obaerved in all aubjecta. 
Aureomycin and terramycin behaved in a aimilar •nner. In one caae, 20 mg 
of aureOIIlJOin orall7 per day for lS da78 produced no appreciable alteratioo 
in the fecal flora except for a 10()-fold increau in yeaat8. In another · 
case, a high doaage {2.S grau aureCJa7Cin orall7 per da7 for 8t da78) 
produced no greater alteration than did the uaual one graa per day. 
Generally the pattern ot alterations in the fecel flora varied conaiderabl7 
fr• •ubjeot to •ubject and fro. organin to organin. 'l'he caanoo pattern• 
ot alteration for each group ot organiaa atudied area 
1. Coliformas The pattern ot alteratioo generally noted in 14 •ubject8 
wa• a decreaM in numbera ot colitOI'Ila quickl7 followe-d by an increaae. 
'nle maxi1111l decrease u•ually occurred on the Hcond or third day following 
the start of the medication. The maximal increaae in population following 
the initial dee reaM occurred in a period trcm 2 to 21 da7a folllring 
ceaaation ot medication. The ••eraae ••• about 6 da78• Another pattern 
ot alteratioa waa noted in 3 subjects in WhCIII there was no appreciable 
change in colitona population throughout the course ot at.ud7. In one 
subject., the Hdicat.ion resulted in ccaplet.e disappearance ot colitorms 
for stool cultures. For all the aubject.a studied, it required a period 
or trCD 0 to lS days following cessation ot the medieatian tor the number 
or e olit orma to ret.um to thei.r pre-drug levels. 
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2. Total aerobes and total anaerobeas Generall7, theM organi ... see•d 
to follow the same patterns aa did the eolitOI'Ils, but their deere•••• in 
numbers during medication waa otten leas marked and in no eaH were they 
elillinated ecapletely. ~~e groupe or llicro-organ1SJU retumed to normal 
in trCIII 0 to 17 dara (average about. 7 daya) following cessation ot JDedieatim. 
3. Yeasta: Yeasta were tound in ll aubjeeta. Onl7 Candida albieana waa 
iaolated trca. 6 ot the ll aubjecta. !he 1'8'Mininc S subjects had £• 
albicana and other ident.itied yeasta. line ot these 11 subjects showed 
a rapid loo-told to l,ooo-told increase without. undergoing an7 initial 
decrease in yeast. poptlat.ion. during sedieat.ion. A period or trca. 0 to 
more than lS days after cessation ot medication waa required tor the yeast. 
counta to return to their pre-drug lenla. In t.hia group tour aubject.a 
who did not. han detectable ;yeaat.a before medication ahowed the presence 
ot and proliferation ot y.aata during and following !Hdicaticm. 'l'he 
reuining 2 or the ll subject. ahowed fluctuations but. no significant. 
increase in the yeasts populati.on during and following the Mdicat.ion. 
4. Staphyloeoccia Staphylococci were studied in 18 caHa. Their reapcmaea 
to aedieation were, in general, leas unitora than in the eau ot the other 
organ1ea studied,. Honver, three ujor patterns ot alteration wre 
maenad. 1n 3 subjects the deere••• or disappearance ot ataph7lococci 
due to medication wa1 quickly followed by an increa•• in the population 
up to or abon pre-drug lenl•• In another 3 1ubjecta there wre SOlie 
fluctuation• but no significant alterations in atapbylococcal populati on• 
due to medieat.iaa. A lOo-t old to l,ooo-toid incre.aee without 1n7 initial 
decrease in population due to medication •• noted in the reuining 12 
1ubject1. It took • period ot frca 2 to lS da71, or slightly longer, tollo. 
ing cessation ot medication for the nUlllber ot 1tlphylococci to return to 
their pre-drug levela tor all aubjecte who had an ineretaein ltlphylo-
eocci. Fi.,. ot the•• 18 aubjecta harbored hnolytic and coaguliiM-poai t1 ve 
Staph. aureu1 and 2 other 1ubject8 harbored coagulase negath·e Staph. 
aureua. 
S. Streptococcu• taecaliea In 8 lubject• there waa increa1e ot loo-told 
to lO,ooo-told in population w1 thout an initial deere••• ·during JHdication. 
Three IUbjects aha.ed onl7 inlignificant fluctuatiODI in the nu.berl of 
Str. taecalia throughout the cour•• ot atudy. In one aubject Str. taeeali• 
- -
d11appeared coapletel7 traa hi• feces tor a day or 10 1hortl7 following 
Mdication. It took traa 0 to 17 daJI tor the nUIIbera ot ~· taecalia 
to return to their pre-drug levell tollawinc c••••tion ot the medication. 
6. Proteu•: Proteu• 'llirabilil •• found in 10 ot the 19 aubjectl atudied. 
Nine aubjecta frOifl whom Proteua could not be iaolated before udication 
ahond the presence ot !. • 11iirab111• on the ncond or third day ot medicaticm. 
In the remaining 1ubjeet, a !• mirabilil earrier, thia organi• d11appaared 
on the 4th day ot medication, followed by a reappearance and a marked rile 
in number• to above the initial pre•drug level. In al.aost all ea•-•• 
rapid prollteratian ot thi1 organim to over 107 org1niaa per gnm ot 
wet feces ••• noticed within 4 daya tolla.ing the appearance or reappearance 
ot the organi•• There ia no evidence that a marked rile in Proteu• cause• 
8'1' 
a dysentery-like diarrhea. It took a period ot tr011 6 to 2$ days toll owing 
cassati on of medication tor the organiam to diaappear or to return to ita 
initial pre-drug level. 
7. PMudaaonaa aeruginola t The atoola ot only one aubjeet ah01ted the 
preaenee ot PHUdOJDonaa on the third day of' medication. It inereaaed in 
numbera to 106 organiams per gram ot wet f'ecea in 2 daya, then began to 
decrease, and f'inaU,- disappeared S days f'ollonna cessation of' aedieation. 
In thia inftatigation with one exception the rapid. proliferation ot 
I 
Proteus, ataphyloeocei, ;ye&a, Str. taeealia, Peeudcaonaa and Other organi.._ 
-
did not cause any cOIDplications. One female subject developed. urethri tie 
due to !.• mirabilia while her fecal Proteua waa rapidly increasing in nUlllber 
toward the end ot udication. Thia organin, identical With the Protaua 
in her feces, waa repeatedl7 iaolated and was the predominant organin in 
the urethral diacharge and f'irat portions ot her urine apecillens. The organ-
ism did not diaappear from her urethral cultures until the ))rd ·post-drug 
day and 24 da;ya following disappearance ot Proteus frOID her fecea. 
In the aerological studies, only 2 ot the Proteus carrying subject. 
showed alight tncreaaes in agglutinen titera. One is the subject who 
developed Proteua urethritia and the other aubject did not experience any 
ill effect fr0111 the overgrowth . ot Proteua in hi a fecea. 
Generall7 speaking, the alteration• ot the fecal flora follOiring oral 
aure0111J(!iD or terram;ycin as reported here are leas marked than those reported 
by other inYe•tigatora. oral adlliniatration of these antibiotics by no 
meana renders the inteatinal tract ate rile. The time .. lilli t for achieving 
a uxilllal effect from the medication ia stressed. Factora contributing to 
differences in experimental results in regard to the effect ot these 
antibiotic• on the fecal flora are diacueaed. Alao given ia an extensive 
review 0t the literature concerning the alterations in intestinal flora 
of man and animals treated with coamonly used antimicrobial agents. 
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